In the Coming EMDEX 2017…
FDA Issues Strongest Warnings on Codeine & Tramadol Labels
FDA now restricts the use of prescription Codeine Pain & Cough medicines and Tramadol Pain medicines in children; recommends against use in breastfeeding women.
Highlights of the labelling changes:
- FDA’s strongest warning, called a Contraindication, to the drug labels of Codeine and Tramadol alerting that Codeine should not be used to treat pain or cough and Tramadol should not be used to treat pain in children younger than 12 years.
- A new Contraindication to the Tramadol label warning against its use in children younger than 18 years to treat pain after surgery to remove the tonsils and/or adenoids.
- A new Warning to the drug labels of Codeine and Tramadol to recommend against their use in adolescents between 12 and 18 years who are obese or have conditions such as obstructive sleep apnea or severe lung disease, which may increase the risk of serious breathing problems.
- A strengthened Warning to mothers that breastfeeding is not recommended when taking codeine or tramadol medicines due to the risk of serious adverse reactions in breastfed infants. These can include excess sleepiness, difficulty breastfeeding, or serious breathing problems that could result in death.
Mild forgetfulness is considered a normal part of ageing – forgetting your car keys, glasses, important dates, etc. Forgetfulness can also be early signs of serious memory problems like dementia or Alzheimer’s disease. Where is the line? When are we supposed to be concerned?
Normal forgetfulness or serious memory problems? Read More
(With excerpts from WHO/FIP Joint Statement on Engaging Pharmacists in Tuberculosis Care and Control – Hyderabad, India, September 4, 2011)
Nigeria is a TB high-burden country – 60% of TB cases worldwide occurred in just 6 countries including Nigeria (WHO Global TB report 2016).
Pharmacies are usually the first port of call for people with TB symptoms. Pharmacists can, therefore, play a frontline role in the care and management of persons living with tuberculosis.
WHO and FIP urge national TB programmes and national pharmacy associations, to develop and implement plans for engaging pharmacists in the fight against TB within the context of national health systems and services. Read More
EMDEX Limited is pleased to announce a new strategic partnership with NV Medical Writing Services as effective from 1st of February 2017.
This partnership is formed with the aim of producing high quality, evidence-based, up-to-date information about drugs and their therapeutic applications, which will be available through EMDEX publications to all healthcare professionals in Nigeria, Africa and the rest of the world.
While NV Medical Writing Services will be the new official medical content creator of EMDEX publications, Read More
For a limited time, EMDEX is giving away FREE EMDEX App Tokens to Medical & Pharmacy Students in Nigeria. Limit of 20 Tokens per School and on a FCFS basis (first come, first served).
The 10-digit Token gives you access to the complete version of EMDEX App. You can purchase the token securely here EmdexOnline.com with prompt delivery to your email address – be sure to enter a valid email address during purchase.
Alternatively, you may call/SMS Nelo 0802.306.0065 for payment information and delivery of your Token via SMS.
To activate your 10-digit Token, follow these steps: Read More